Pfizer’s axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints
Pfizer’s axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Read more on News-Medical-Net
Categories: Breast Cancer Information Tags: advanced, axitinib, carcinoma, Cell, endpoints, meets, Pfizer's, Phase, Primary, Renal, Trial
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate that is being developed for the treatment of metastatic renal cancer.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Treatment Tags: affiliate, Agensys, AGS16M8F, Announces, Astellas, cancer, Clinical, initiation, Phase, Renal, Trial
Statins And The Risk Of Liver Dysfunction, Acute Renal Failure, Cataracts And Myopathy
Statins And The Risk Of Liver Dysfunction, Acute Renal Failure, Cataracts And Myopathy
Patients who are prescribed statins for heart disease should be closely monitored, because of the risk of unintended adverse effects (side effects), say researchers in a study published in the British Medical Journal (BMJ) today. A number of statins may raise the risk of liver dysfunction, acute renal failure, myopathy (diseases of muscle), and cataracts. The authors write that cardiovascular …
Read more on Medical News Today
Categories: High Risk Breast Cancer Tags: acute, Cataracts, Dysfunction, Failure, liver, Myopathy, Renal, Risk, Statins